Armenia’s monetary base shrinks 0.5% to AMD 719.1 billion in October

YEREVAN, November 29. /ARKA/. Armenia’s monetary base contracted by 0.5% in October, compared with September, to about AMD 719.1 billion, the National Statistical Service reported today referring to the central bank’s preliminary figures.

Cash outside of the central bank amounted to AMD 408.6 billion in October against AMD 408 billion in September.

Mandatory reserves in drams totaled over AMD 178.5 billion in late October after shrinking 1.9% over the month, and those in foreign currencies grew 0.5% to AMD 129 billion.

Net international reserves less funds from privatization grew 27.4% in October, compared with September, to about AMD 493.1 billion.

Net internal assets totaled over AMD 225.9 billion against about AMD 43.7 billion in September. ($1 – AMD 403.92). —0—-

spot_img

POPULAR

Armenian dram weakened against the dollar and strengthened against the euro and ruble: Central Bank

The average market exchange rate for the US dollar to the Armenian dram, formed on the Armenian foreign exchange market as of August 24, 2026, increased by 0.22 points to 365.38 drams compared to August 21.

An Armenian Business Founded in a Garage: Games for Live Communication with the Support of Acba Bank

The success story of board games created by David Hovhannisyan began in a small garage near his home. David and his friends created educational games during their student years; as the number of orders grew, they decided to expand the business.

Armenian banks’ investments in securities in the second quarter amounted to 1.92 trillion drams

The total volume of investments by Armenian commercial banks in securities as of the end of June 2026 amounted to 1,922,826,829 thousand drams.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

S&P affirms Armenia’s ratings, maintaining a positive outlook

The international rating agency S&P Global Ratings affirmed the long- and short-term sovereign ratings of the Republic of Armenia at 'BB-/B', maintaining a positive outlook, the Ministry of Finance reported.

LATEST NEWS

spot_imgspot_imgspot_img